The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Abstract
Thrombocytopenia is a frequent side effect of cancer chemotherapy and commonly limits attempts to escalate drug doses. To determine whether interleukin-1α could ameliorate carboplatin-induced thrombocytopenia, we combined it with high-dose carboplatin in 43 patients with advanced neoplasms.

This publication has 25 references indexed in Scilit: